Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. - Kan,S.H.; Elanko,N.; Johnson,D.; Cornejo-Roldan,L.; Cook,J.; Reich,E.W. (Am J Hum Genet, 2002)